
Iminosugars: From Synthesis to Therapeutic Applications
by Editor: Philippe Compain (Institut de Chimie Organique et Analytique, Universite d?Orleans, France); Editor: Olivier R. Martin (Institut de Chimie Organique et Analytique, Universite d?Orleans, France)-
This Item Qualifies for Free Shipping!*
*Excludes marketplace orders.
Rent Textbook
New Textbook
We're Sorry
Sold Out
Used Textbook
We're Sorry
Sold Out
eTextbook
We're Sorry
Not Available
Summary
Table of Contents
Foreward | |
Preface | |
List of Contributors | |
Iminosugars: past, present and future | |
Naturally occurring iminosugars and related alkaloids: structure, activity and applications | |
Introduction | |
?-Glucosidase inhibitors | |
ß-Glucosidase inhibitors | |
?- and b-Galactosidase inhibitors | |
?-Mannosidase inhibitors | |
Concluding remarks and future prospects | |
References | |
General strategies for the synthesis of iminosugars and new approaches towards iminosugar libraries | |
Introduction | |
Monocyclic compounds | |
1-N-Iminosugars | |
Bicyclic compounds | |
Other bicyclic compounds | |
Iminosugar conjugates | |
Conclusions | |
References | |
Iminosugar C-glycosides: synthesis and biological activity | |
Introduction | |
Synthesis of iminosugar C-glycosides | |
Biological activity of iminosugar C-glycosides | |
Conclusion | |
References | |
Imino-C-disaccharides and analogues: synthesis and biological activity | |
Introduction | |
Synthesis of imino-C-disaccharides | |
Conformations of imino-C-disaccharides | |
Glycosidase inhibitory activities of imino-C-disaccharides | |
Efficient combinatorial method for the discovery of glycosidase inhibitors | |
Antitumour activity of new a-mannosidase inhibitors | |
Conclusion | |
References | |
Isofagomine, noeuromycin and other 1-azasugars, iminosugar related glycosidase inhibitors | |
Introduction | |
1-Azasugars that are piperidines (isofagomine, noeuromycin, etc. | |
1-Azasugars that are hydrazines | |
1-Azasugars that are oxazines | |
1-Azasugars that are piperidones | |
Sulphur-containing analogues of 1-azasugars | |
Slow inhibition and thermodynamics of binding | |
Are 1-azasugars (and iminosugars) transition state analogues? | |
References | |
Iminosugar-based glycosyltransferase inhibitors | |
Biological role and structural features of glycosyltransferases | |
Development of inhibitors of glycosyltransferases | |
Conclusion | |
References | |
Transition state analogue inhibitors of N-Ribosyltransferases | |
Introduction | |
Nucleoside hydrolases | |
Purine nucleoside phosphorylases (PNPs | |
5'-Methylthioadenosine (MTA) nucleosidases and phosphorylases | |
Ricin A-chain | |
Summary and conclusions | |
References | |
Iminosugars as antiviral agents | |
Introduction | |
The relationship between glucosidase inhibition and antiviral action | |
Fate of viral glycoproteins in glucosidase-inhibited cells | |
Specificity of glucosidase inhibition | |
N-Alkyl DNJs inhibit virus growth by non-glucosidase inhibitory mechanisms - other potential activities of these compounds | |
New directions for improving glucosidase inhibitors as antiviral agents | |
References | |
Iminosugars as active-site-specific chaperones for the treatment of lysosomal storage disorders | |
Introduction | |
Degradation of glycosphingolipids | |
Lysosomal enzyme biosynthesis and ER-associated degradation (ERAD | |
Active-site-specific chaperones and iminosugars | |
Basic requirements for effective ASSCs | |
Identification of ASSCs | |
Examples of ASSC therapy for lysosomal storage disorders | |
Future perspectives | |
References | |
Iminosugar inhibitors for substrate reduction therapy for the lysosomal glycosphingolipidoses | |
Glycolipid lysosomal storage diseases | |
Options for glycosphingolipidosis therapy | |
Iminosugars for substrate reduction therapy | |
Iminosugars as inhibitors of glycolipid biosynthesis | |
SRT combination therapy | |
Prospects for iminosugars as therapeutics | |
References | |
Iminosugar-based antitumoural agents | |
Introduction | |
Hexose-mimetic iminosugars | |
Hexuronic acid-mimetic iminosugars | |
Concluding remarks | |
References | |
Medicinal use of iminosugars | |
Introduction | |
Recent pharmaceutical developments | |
Clinical application of iminosugars as medicines | |
Conclusions | |
References | |
Tables of iminosugars, their biological activities and their potential as therapeutic agents | |
Introduction | |
Type 2 diabetes | |
Antiviral activities | |
Antibacterial activities | |
Antiprotozoal activities | |
Antiparasitarial activities | |
Cancer | |
Lysosomal diseases | |
Immunomodulating agents | |
Antipsoriatic agents | |
Antifungal agents | |
Cystic fibrosis | |
Infertility inducing agents | |
Chondroprotective agents | |
Inflammatory diseases | |
Appetite suppressing agents | |
Nematicidal activity | |
Insecticidal activity | |
References | |
Index | |
Table of Contents provided by Publisher. All Rights Reserved. |
An electronic version of this book is available through VitalSource.
This book is viewable on PC, Mac, iPhone, iPad, iPod Touch, and most smartphones.
By purchasing, you will be able to view this book online, as well as download it, for the chosen number of days.
Digital License
You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.
More details can be found here.
A downloadable version of this book is available through the eCampus Reader or compatible Adobe readers.
Applications are available on iOS, Android, PC, Mac, and Windows Mobile platforms.
Please view the compatibility matrix prior to purchase.